口服多克索菲林和普罗卡特罗尔对慢性阻塞性肺病的影响:一项随机交叉研究
Narongkorn Saiphoklang1, Sarawut Panichaporn1, Thiravit Siriyothipun1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
Medical sciences (Basel, Switzerland)
|May 23, 2025
概括
口服多克索菲林在慢性阻塞性肺病 (COPD) 患者中改善了肺功能,但引起的神经系统副作用比前醇更多. 两种药物都没有显著改善临床症状或步行距离.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口服支气管扩展剂正在作为慢性阻塞性肺病 (COPD) 的辅助疗法进行探索.
- 考索菲林和普拉卡特罗尔对COPD患者的影响进行了评估.
研究的目的:
- 在COPD患者中比较口服多克索菲林与口服公醇的疗效.
- 评估对肺功能,临床症状和不良事件的影响.
主要方法:
- 一个交叉随机对照试验,涉及稳定的COPD患者.
- 通过螺旋计,mMRC,CAT分数和6MWD评估肺功能.
- 在4周的治疗期内对多克索菲林和普拉卡特罗尔进行比较,并进行1周的洗.
主要成果:
- 德克索菲林显著改善了支气管扩展器后的最大呼气流量和25-75强迫呼气流量,相比于prokaterol.
- 两组之间没有观察到mMRC,CAT得分或6MWD的显著差异.
- 神经学不良事件更频繁地发生在多克索菲林 (35%) 而不是procaterol (5%).
结论:
- 德克索菲林可以增强COPD患者的肺功能,但其功能性能并不优于普罗卡特罗尔.
- 多克索菲林与神经系统副作用的发病率较高有关.
- 德克索菲林可以被认为是改善COPD肺功能的辅助疗法,并仔细监测不良事件.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
336
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
336
Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K


